On the afternoon of April 7, Shenzhen Nanshan District Committee Secretary Wang Qiang and Nanshan District Deputy Director Lian Cong led a multi-departmental visiting group including District development and reform bureau, science and technology innovation bureau, industry and information bureau, health bureau, statistics bureau, enterprise service center, Nantou street Committee, etc. to visit CMS Pharmaceutical Company. Chairman and Chief Executive Officer of CMS Group, Lin Gang with group executives warmly welcomed secretary Wang Qiang and other leaders to visit the Shenzhen headquarter of CMS.
Ms. Chen Yanling, Vice President and Chief Financial Officer of CMS Group, thanked the leaders of Nanshan District for their care and support to CMS, and introduced in detail the development of CMS for more than 20 years, including its business layout, business development, innovation research and patent application. CMS is a global innovation-driven, professional pharmaceutical enterprise focusing on the Chinese market. It has won the recognition of the capital market by its robust professional management style and growing business performance. It was selected into the “Hang Seng Stock Connect Biotech 50 Index” and the “CNI Nanshan 50 Index” at the end of last year. In recent years, CMS has accelerated the research and development of innovative drugs, and has invested in 7 R & D companies in the United States, the United Kingdom, Switzerland, and France. At the same time, CMS has cooperated strategically with well-known international pharmaceutical companies in India and Israel to obtain the rights of 19 innovative pharmaceuticals in China or the Greater China region. CMS will speed up the marketing process of innovative drugs ,according to the different characteristics of each drug, to bring more advanced and cost-effective treatment regimens to Chinese patients.
At the symposium, Secretary Wang Qiang carefully inquired about the company’s resumption of work and the development of CMS. The heads of the various functional departments in Nanshan District introduced the preferential policies of enterprises and made practical suggestions for the development of CMS. Wang Qiang said that the Nanshan District will cultivate and develop the biological and pharmaceutical industry, expressing great affirmation on the innovative and developing Model of CMS. He hoped that CMS could strengthen R & D efforts, integrate the industrial chain, seize the development opportunities of the biological and pharmaceutical industry, and occupy the commanding heights of industry development. At the same time, he said that the government will do a better service to troubleshoot problems for enterprise development, and help enterprises grow bigger and stronger.
